High Net Worth Advisory Group LLC Gilead Sciences, Inc. Transaction History
High Net Worth Advisory Group LLC
- $359 Million
- Q2 2025
A detailed history of High Net Worth Advisory Group LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, High Net Worth Advisory Group LLC holds 3,894 shares of GILD stock, worth $429,430. This represents 0.12% of its overall portfolio holdings.
Number of Shares
3,894
Previous 3,894
-0.0%
Holding current value
$429,430
Previous $436,000
1.15%
% of portfolio
0.12%
Previous 0.13%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,294Shares Held
1BCall Options Held
9.56MPut Options Held
9.96M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.56 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.02 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.91 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...